Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 31.01%
March 31, 2026 30.37%
December 31, 2025 34.57%
September 30, 2025 32.71%
June 30, 2025 32.21%
March 31, 2025 33.71%
December 31, 2024 34.62%
September 30, 2024 34.18%
June 30, 2024 33.70%
March 31, 2024 29.45%
December 31, 2023 34.76%
September 30, 2023 32.70%
June 30, 2023 36.59%
March 31, 2023 33.19%
December 31, 2022 37.09%
September 30, 2022 38.80%
June 30, 2022 36.35%
Date Value
March 31, 2022 30.67%
December 31, 2021 34.44%
September 30, 2021 36.93%
June 30, 2021 37.61%
March 31, 2021 34.52%
December 31, 2020 34.92%
September 30, 2020 39.73%
June 30, 2020 38.72%
March 31, 2020 33.01%
December 31, 2019 39.98%
September 30, 2019 36.08%
June 30, 2019 27.53%
March 31, 2019 32.35%
December 31, 2018 32.69%
September 30, 2018 31.87%
June 30, 2018 24.95%
March 31, 2018 31.14%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Viva Biotech Holdings --
ICON plc 18.83%
Proteome Sciences Plc --
Champions Oncology, Inc. 48.48%
SPO Global, Inc. --